University Miami (UM) - Miami is one ofthe largest metropolitan areas in the United States with the highest incidence of HIV-1 infecfion. Approximately 125,000 people are living with HIV in Florida (3'*^ in the nation) and 67% are black or Hispanic (Florida Department of Health, HIV/AIDS Fact Sheet, 2008). Miami Dade County accounts for 20% of those with HIV infection in the state. HIV/AIDS is the number one cause of death in African Americans ages 25-44. In Miami-Dade County, HIV-infected patients are primarily followed at our affiliated Jackson Memorial Hospital (JMH), a 1500-bed tertiary facility that serves an inner-city, indigent, and minority population and at UM's AIDS Clinical Research Unit (ACRU) directed by Dr. Margaret FischI. More recently, UM has expanded its clinical and teaching operations acquiring a 560-bed facility adjacent to our cancer center in the heart of Miami. The HIV program at UM/JMH has existed since the eariy 1980's and has contributed significanfiy to HIV dinical care and research. The adult HIV outpatient program follows approximately 2,600 HIV-infected adult individuals with over 8,000 outpatient visits a year. Approximately 30% are female, 45% African-American, 15% Haifian-American, 30% Hispanic-American, and the remainder Euro- American.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA121947-07
Application #
8549968
Study Section
Special Emphasis Panel (ZCA1-SRLB-D)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
7
Fiscal Year
2013
Total Cost
$584,308
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Goldstone, Stephen E; Lensing, Shelly Y; Stier, Elizabeth A et al. (2018) A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in HIV-infected adults: An AIDS Malignancy Consortium trial. Clin Infect Dis :
Bender Ignacio, Rachel; Lin, Lilie L; Rajdev, Lakshmi et al. (2018) Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials. J Natl Compr Canc Netw 16:1018-1026
Ellsworth, G B; Lensing, S Y; Ogilvie, C B et al. (2018) A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men. Papillomavirus Res 6:11-14
Schneider, Johann W; Dittmer, Dirk P (2017) Diagnosis and Treatment of Kaposi Sarcoma. Am J Clin Dermatol 18:529-539
Palefsky, Joel M (2017) Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS 12:26-30
Faggons, Claire E; Mabedi, Charles E; Liomba, N George et al. (2017) Human papillomavirus in head and neck squamous cell carcinoma: A descriptive study of histologically confirmed cases at Kamuzu Central Hospital in Lilongwe, Malawi. Malawi Med J 29:142-145
Raghavendran, Anantharam; Hernandez, Alexandra L; Lensing, Shelly et al. (2017) Genital Human Papillomavirus Infection in Indian HIV-Seropositive Men Who Have Sex With Men. Sex Transm Dis 44:173-180
Danilov, Alexey V; Li, Hongli; Press, Oliver W et al. (2017) Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leuk Lymphoma 58:461-465
Oliver, Nora T; Chiao, Elizabeth Y (2017) Malignancies in women with HIV infection. Curr Opin HIV AIDS 12:69-76
Chinula, Lameck; Moses, Agnes; Gopal, Satish (2017) HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. Curr Opin HIV AIDS 12:89-95

Showing the most recent 10 out of 123 publications